Le Lézard
Classified in: Health
Subject: PDT

Vision Films to Release Powerful Dementia Tale 'Ruby's Choice' Starring Jane Seymour


LOS ANGELES, April 23, 2024 /PRNewswire/ -- After successful theatrical and television runs in Australia and New Zealand, Vision Films announces the limited theatrical release on April 26, 2024 of the Jane Seymour starrer Ruby's Choice, followed by the North American Transactional VOD release on May 7. Directed and produced by Michael Budd, written by Paul Mahoney, produced by Jessica Butland, Holly Brisley, Bianca Wei, Allison Berger, and executive produced by Sir Owen Glenn and Budd, the film was acquired in a deal with Carlos Alperin and his Australian sales company Galloping Entertainment. It racked up many festival awards and achievements both in the US and abroad, including a double victory at the 2023 Burbank International Film Festival (BIFF) where it won Best Foreign Film and Best Feature Film. 

A limited theatrical run starts on April 26, 2024 at The Laemmle Town Center in Encino, CA including a Q&A with Jane Seymour after the matinee on Sunday, April 28. Please visit laem.ly/3VOhR0l for more details and tickets. The movie will open the same day at the Old Mill Playhouse in The Villages, FL.

Jane Seymour, known for her celebrated career ranging from the 1973 Bond girl "Solitaire" to Dr. Quinn Medicine Woman and more recently The Kaminsky Method, embraces one of the most powerful and emotionally charged roles of her career. Ruby's Choice intricately weaves a poignant narrative around a teenage girl whose life takes a profound turn when she shares her space with her grandmother (Seymour) battling dementia. What begins as initial resentment transforms into a journey of love, self-discovery, and the revelation of long-held family secrets.

Watch the trailer HERE.

The film stars Jane Seymour, Jacqueline McKenzie (Deep Blue Sea), Coco Jack Gillies (Mad Max: Fury Road), Stephen Hunter (The Hobbit: An Unexpected Journey), Rory Potter (The Dressmaker).

Lise Romanoff, CEO and Managing Director of Vision Films shares, "This is a beautiful film about the very real impact dementia has on a family. Jane Seymour's performance is beautiful, moving, and puts a realistic face to such a pervasive and difficult disease."

Director Michael Budd says, "The issue of Dementia is very much a personal one. I was inspired to make Ruby's Choice, having lost my grandmother, who suffered from Dementia. I wanted to create a movie that tells a beautiful story about family love and Dementia through three generations of inspiring women. My hope in making this film is that we can open a conversation about a subject of significant importance to make the process easier for their loved ones and themselves."

Jane Seymour adds, "I am thrilled that this film will now be able to reach audiences across the US and Canada. Alzheimer's is a disease that affects so many around the world. Ruby's Choice presents to audiences a unique perspective on this disease and I'm hopeful that the messaging within the film can provide comfort and positivity for many."

Ruby's Choice is set for TVOD release simultaneously in the United States and in the United Kingdom on May 7, 2024 followed by DVD at major online retailers.

About Vision Films

Vision Films is a leading independent sales and VOD aggregator specializing in the licensing, marketing, and distribution of over 800 feature films, documentaries, and series from some of the most prolific independent film producers in the world. Led by Lise Romanoff, Managing Director/CEO Worldwide Distribution, Vision Films releases 2-4 films a month across Theatrical, VOD, DVD, and television platforms. visionfilms.net

Media Contact:
Andrea McKinnon
8184159442
[email protected]

SOURCE Vision Films, Inc.


These press releases may also interest you

at 22:51
Chemistree Technology Inc. and (US OTC: CHMJF) (the "Company" or "Chemistree"), announces that its board of directors (the "Board") has approved a restructuring transaction (the "Restructuring Transaction"), pursuant to which all of the principal of...

at 21:00
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting. The...

at 20:26
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...

at 20:00
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident. What Happened? On March 5, 2024, AD detected it was the...

at 19:19
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...

at 19:01
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...



News published on and distributed by: